Result of AGM

For immediate release 27 July 2006

                      Proteome Sciences Plc ("Proteome")                       

                                 Result of AGM                                 

The Board of Proteome announces that at its Annual General Meeting held today
all resolutions were duly passed.

Notes to editors:

Proteome Sciences plc

Proteome Sciences, a global leader in applied proteomics, uses high sensitivity
proprietary technologies to detect differentially expressed proteins in
diseases. The protein biomarkers discovered in body fluids or tissues are
validated, developed and commercialised as diagnostic, prognostic or
therapeutic products through strategic alliances and out-licensing.

Through its unique ProteoSHOP® toolbox, Proteome Sciences provides high
sensitivity/high throughput proteomics solutions, including traditional two
dimensional gel-based electrophoresis (2DE) and proprietary gel-free protein
sequence tag technologies (PST®, qPSTtm& TMT®), to major pharma, biotechnology
and diagnostic companies, to discover and exploit protein biomarkers.
Sensitizer® chemical mass tags have been developed separately as a series of
stand-alone reagents.

For further information please visit www.proteomics.com .

Enquiries:

Proteome Sciences plc

Christopher Pearce, Chief Executive Officer

Email: [e-mail]

Tel: [phone]

Public Relations for Proteome Sciences

IKON Associates

Adrian Shaw

Tel: [phone]

Mobile: [phone]

Email: [e-mail]